Efficacy and safety of peficitinib in rheumatoid arthritis.

Kaneko, Yuko

Kaneko, Yuko.

Affiliation

Kaneko Y; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.

Mod Rheumatol ; 30(5): 773-778, 2020 Sep.

Article in En | MEDLINE | ID: mdl-32643492

Subject(s)

Adamantane/analogs & derivatives; Antirheumatic Agents/therapeutic use; Arthritis, Rheumatoid/drug therapy; Clinical Trials, Phase II as Topic; Niacinamide/analogs & derivatives; Protein Kinase Inhibitors/therapeutic use; Adamantane/administration & dosage; Adamantane/adverse effects; Adamantane/therapeutic use; Antirheumatic Agents/administration & dosage; Antirheumatic Agents/adverse effects; Herpes Zoster/epidemiology; Herpes Zoster/etiology; Humans; Janus Kinases/antagonists & inhibitors; Niacinamide/administration & dosage; Niacinamide/adverse effects; Niacinamide/therapeutic use; Protein Kinase Inhibitors/administration & dosage; Protein Kinase Inhibitors/adverse effects

Key words

Rheumatoid arthritis; janus kinase; peficitinib

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Adamantane / Clinical Trials, Phase II as Topic / Niacinamide / Antirheumatic Agents / Protein Kinase Inhibitors Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google